Vogenx, Inc.

US$17.45As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VOGXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$259.2M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$22
26.24%
(77.12%)
Hold 2|12|11|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.18
0.19
0.19
0.20
19.39%
25.07%
11.46%
16.13%
Revenue$M
21.43
22.25
22.21
21.92
15.79%
18.33%
15.72%
8.13%
Peers (US$259.2M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.531
(0.027)
(0.015)
EBIT/Intx
0.834
0.098
0.084
Own earn%
(91.87)
50.92
26.65
Sh yield%
49.86
30.62
25.99
Owners
Insiders/Inst%
7.21
27.24
Short interest%
3.03
SBC / revenue%
1.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
7–14
$1 testx
0.0
Incr. ROIC%
5